s6y
Company name or ticker
Search
Prelude Therapeutics Inc
4
Morris Charles Q: Statement of changes in beneficial ownership of securities
Filed
Monday, May 4, 2026
Period
May 1, 2026
Accession number
0001489966-26-000004
Documents
PRIMARY DOCUMENT
4
On sec.gov
Filing index
All files
Complete submission text
SGML header